Neoadjuvant immune checkpoint inhibitor therapy and chemotherapy improve pulmonary ventilation and diffusion function in patients with lung cancer

Author:

BAO Wu’an,ZHOU Xia,GU Feiying,LIN Juan,LI Bin

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine

Reference17 articles.

1. ARELLANO E A, DÍAZ V D, RODRÍGUEZ J. Current status and future directions in unresectable stage Ⅲ non-small cell lung cancer[J]. J Clin Transl Res, 2020, 6(4): 109-120..

2. 杨森, 谢颂平, 黄杰. 可手术切除的局部进展期非小细胞肺癌患者新辅助治疗研究进展[J]. 实用心脑肺血管病杂志, 2022, 30(3): 131-136..

3. YANG Sen, XIE Songping, HUANG Jie. Progress of neoadjuvant therapy for resectable locally advanced non-small cell lung cancer[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2022, 30(3): 131-136. (in Chinese).

4. DOVEDI S J, ADLARD A L, LIPOWSKA-BHALLA G. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res, 2014, 74: 5458-5468.

5. HERRERA F G, BOURHIS J, COUKOS G. Radio-therapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J Clin, 2017, 67: 65-85.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3